EVENT DOSSIER · 2027

BioPharma Drug Discovery Nexus (spring US edition)

2027 dates to confirm · United States · TBA (2026: Philadelphia)

Official website / registration ↗

Personal decisionLoading…Personal objectives & notes (only you)

Company decisionLoading…Company planning notes (this account)

Other attendees & event notes

Manual list only; no invitations are sent. Visible only within this account.

Other attendees (you may include yourself)Event notes

Plan your participation

Date status: Series watch; 2027 specifics not yet established
Venue: TBA (2026: Philadelphia)
Registration fees: Current-edition rate not verified; check official pass types
Attendance: No verified current-edition count or attributable prior-edition figure
Partnering: Primarily technical exchange; formal partnering to verify
Exhibition / sponsorship: Verify edition-specific booth and sponsorship packages; delegate registration is not booth pricing
Deadlines: Abstract, early-rate, exhibit and partnering deadlines differ; unverified dates are not inferred

Official sources & review record

Imported reference (not independently verified)

Submitted date: TBA (est. May)

Ticket reference: Not published

Audience reference: Pharma & Biotech - 76%; C-Level Executives - 29%; Directors - 13%; Vice Presidents - 10%

Audience: Pharma/biotech discovery & BD leaders (76% pharma/biotech; C-level 29%, Directors 13%, VPs 10%)

Historical years and pass eligibility are retained; these are not confirmed 2027 rates or attendance figures.

Organizer link supplied with import; not independently checked ↗Checked: 2026-11-07

Core-event labels are editorial selections, not organizer endorsements. Fees and scale are source snapshots, not guaranteed final prices or attendance.